Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Feb 16, 2024 (filed on Feb 16, 2024)Insider Name:Fairmount Funds Management LLCOwnership Type:Indirect OwnershipSecurities:Series B Convertible Preferred StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,500Price:$7,500.00
-
Feb 16, 2024 (filed on Feb 16, 2024)Insider Name:Fairmount Funds Management LLCOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,166,666Price:$7.50
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Robinson John EdwardOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:300,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Kearns EvanOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:255,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Sachs JessicaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:300,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Robbins Andrew ROwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,100,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Green John L.Ownership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:300,000Price:--
-
Jan 02, 2024 (filed on Jan 04, 2024)Insider Name:Ferrante Karen JeanOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,298Price:--
-
Jan 02, 2024 (filed on Jan 04, 2024)Insider Name:Ros MatthewOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,051Price:--
-
Oct 02, 2023 (filed on Oct 03, 2023)Insider Name:Ros MatthewOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,170Price:--
Filings by filing date
-
Feb 16, 2024 (filed on Feb 16, 2024)Insider Name:Fairmount Funds Management LLCOwnership Type:Indirect OwnershipSecurities:Series B Convertible Preferred StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,500Price:$7,500.00
-
Feb 16, 2024 (filed on Feb 16, 2024)Insider Name:Fairmount Funds Management LLCOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,166,666Price:$7.50
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Robinson John EdwardOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:300,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Kearns EvanOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:255,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Sachs JessicaOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:300,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Robbins Andrew ROwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,100,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Green John L.Ownership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:300,000Price:--
-
Jan 02, 2024 (filed on Jan 04, 2024)Insider Name:Ferrante Karen JeanOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,298Price:--
-
Jan 02, 2024 (filed on Jan 04, 2024)Insider Name:Ros MatthewOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,051Price:--
-
Oct 02, 2023 (filed on Oct 03, 2023)Insider Name:Ros MatthewOwnership Type:Direct OwnershipSecurities:Stock Option (Right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,170Price:--
News
Biz Brief
Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 275 Wyman Street, 3Rd Floor WALTHAM MA 02451 |
Tel: | N/A |
Website: | https://www.cogentbio.com |
IR: | See website |
Key People | ||
Andrew Robbins President, Chief Executive Officer, Principal Executive Officer, Director | John L. Green Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer | John Robinson Chief Scientific Officer |
Jessica Sachs Chief Medical Officer | Evan D. Kearns Chief Legal Officer, Corporate Secretary |
Business Overview |
N/A |
Financial Overview |
For the fiscal year ended 31 December 2023, Cogent Biosciences Inc revenues was not reported. Net loss increased 37% to $192.4M. Higher net loss reflects Research and development - Balancing va increase of 39% to $120.1M (expense), Labor & Related Expenses in R&D increase of 45% to $39.1M (expense), Stock-based Compensation in SGA increase of 63% to $16M (expense). |
Employees: | 164 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $417.72M as of Dec 31, 2023 |
Annual revenue (TTM): | $0.00M as of Dec 31, 2023 |
EBITDA (TTM): | -$205.86M as of Dec 31, 2023 |
Net annual income (TTM): | -$192.41M as of Dec 31, 2023 |
Free cash flow (TTM): | -$156.42M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 95,613,396 as of Mar 25, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |